D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Rapid7
RPD
$1.27B
| $16.6M | 0.02% |
327,034
+155,068
| +90% | +$7.85M |
|
602
Avanos Medical
AVNS
$569M
| $16.5M | 0.02% |
387,603
+41,508
| +12% | +$1.77M |
|
|
NVTA
603
DELISTED
Invitae Corporation
NVTA
| $16.5M | 0.02% |
702,499
+43,878
| +7% | +$1.03M |
|
604
Clorox
CLX
$15.1B
| $16.4M | 0.02% |
102,458
+99,758
| +3,695% | +$16M |
|
|
NSTG
605
DELISTED
NanoString Technologies, Inc.
NSTG
| $16.4M | 0.02% |
686,313
+351,638
| +105% | +$8.41M |
|
606
Credicorp
BAP
$20.8B
| $16.4M | 0.02% |
68,344
-27,473
| -29% | -$6.59M |
|
607
Brookdale Senior Living
BKD
$1.75B
| $16.4M | 0.02% |
2,487,210
+527,121
| +27% | +$3.47M |
|
|
AJRD
608
DELISTED
Aerojet Rocketdyne Holdings, Inc.
AJRD
| $16.4M | 0.02% |
460,397
+81,940
| +22% | +$2.91M |
|
609
Portland General Electric
POR
$4.65B
| $16.3M | 0.02% |
315,052
-362,490
| -54% | -$18.8M |
|
610
Inspire Medical Systems
INSP
$2.36B
| $16.3M | 0.02% |
286,976
+227,438
| +382% | +$12.9M |
|
611
Glaukos
GKOS
$5.06B
| $16.2M | 0.02% |
206,870
+111,932
| +118% | +$8.77M |
|
612
Acco Brands
ACCO
$370M
| $16.1M | 0.02% |
1,875,701
+29,189
| +2% | +$250K |
|
613
C.H. Robinson
CHRW
$15.4B
| $16.1M | 0.02% |
184,527
-88,342
| -32% | -$7.68M |
|
|
DISH
614
DELISTED
DISH Network Corp.
DISH
| $16M | 0.02% |
505,850
-12,643
| -2% | -$401K |
|
615
Benchmark Electronics
BHE
$1.44B
| $15.9M | 0.02% |
605,546
+20,992
| +4% | +$551K |
|
616
Leidos
LDOS
$23.6B
| $15.8M | 0.02% |
247,183
-19,439
| -7% | -$1.25M |
|
617
Gildan
GIL
$8.2B
| $15.8M | 0.02% |
437,700
-83,241
| -16% | -$3M |
|
618
SPX Corp
SPXC
$9.45B
| $15.7M | 0.02% |
452,687
-116,712
| -20% | -$4.06M |
|
619
Strategy Inc Common Stock Class A
MSTR
$92.4B
| $15.7M | 0.02% |
1,089,300
-956,640
| -47% | -$13.8M |
|
|
BID
620
DELISTED
Sotheby's
BID
| $15.7M | 0.02% |
416,249
-38,559
| -8% | -$1.46M |
|
621
Bright Horizons
BFAM
$6.41B
| $15.7M | 0.02% |
123,374
+42,801
| +53% | +$5.44M |
|
622
Repligen
RGEN
$6.81B
| $15.6M | 0.02% |
263,971
-2,659
| -1% | -$157K |
|
623
COPT Defense Properties
CDP
$3.48B
| $15.5M | 0.02% |
566,930
-408,409
| -42% | -$11.1M |
|
|
AXE
624
DELISTED
Anixter International Inc
AXE
| $15.4M | 0.02% |
274,711
+27,802
| +11% | +$1.56M |
|
625
Melco Resorts & Entertainment
MLCO
$3.83B
| $15.4M | 0.02% |
681,380
-696,263
| -51% | -$15.7M |
|